Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross margin | 75.8% | 77.6% | 79.0% | 79.7% | 79.1% | 82.4% | 80.8% | 82.1% | 80.7% | 79.5% | 77.6% | 81.2% | 82.1% | 80.8% | 77.7% | 79.8% | 80.1% | 66.8% | 72.1% | 82.4% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Gross margin is 81.1%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Gross margin for AstraZeneca PLC have been 75.3% over the past three years, and 80.4% over the past five years.
As of today, AstraZeneca PLC's Gross margin is 81.1%, which is higher than industry median of 69.6%. It indicates that AstraZeneca PLC's Gross margin is Good.